Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)
HETALCEV
1 other identifier
interventional
8
1 country
1
Brief Summary
A device has been developed that has eye trackers integrated within the Head Mounted Display (HMD) and can remap text and images around the scotoma in real time to prevent information loss from a central scotoma. It can also carry out other types of image processing such as contrast enhancement and image magnification. The aim of this study is to assess the efficacy of this device on the visual performance of participants suffering from central vision loss, with and without remapping
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 13, 2016
CompletedFirst Posted
Study publicly available on registry
July 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedJune 20, 2024
June 1, 2024
7 years
June 13, 2016
June 17, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reading speed
words/minute
5 years
Study Arms (2)
small scotoma using Head Mounted Display No re-mapping
ACTIVE COMPARATORpatients with scotoma smaller than 5 degrees NO re-mapping PLUS re-mapping
Large scotoma using Head Mounted Display PLUS re-mapping
ACTIVE COMPARATORpatients with scotoma larger than 5 degrees NO re-mapping PLUS re-mapping
Interventions
re-mapping software turned off
re-mapping software turned on
Eligibility Criteria
You may qualify if:
- years or older
- Central vision loss from bilateral central scotomas
- No cognitive impairment as indicated by a Mini-Mental State Examination (MMSE)
You may not qualify if:
- Failed MMSE
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University _of_Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Erik van Kuijk, MD, PhD
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2016
First Posted
July 12, 2016
Study Start
April 1, 2016
Primary Completion
April 1, 2023
Study Completion
May 1, 2024
Last Updated
June 20, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share
participants will be de-identified